Monographie - Hydrochlorothiazide - Stabilis 4.0

最新更新 :
14/02/2025

利尿剂

Hydrochlorothiazide

口服剂

制剂的稳定性

混合物稳定性

影响稳定性的因素

兼容性

引用文献

PDF

化学式

口服剂

引用文献

口服剂

引用文献 : Hydrochlorothiazide

	种类	出版物
2435	文献	Allen LV, Jr, Erickson MA, Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids Am J Health-Syst Pharm 1996 ; 53: 2304-2309.
3361	文献	Santovena A, Hernandez-Paiz Z, Farina J.B. Design of a pediatric oral formulation with a low proportion of hydrochlorothiazide. Int J Pharm 2012 ; 423: 360-364.
3399	海报	Li Y.Y, Postma D.J, Wagenaar H.W.G. Development of a hydrochlorothiazide 0.5 mg/mL oral solution for children. EAHP Congress Paris 2013
3910	文献	Polonini H.C, Silva S .L, de Almeida T.R, Brand?o M.A, Ferreira A.O. Compatibility of caffeine, carvedilol, clomipramine hydrochloride, folic acid, hydrochlorothiazide, loperamide hydrochloride, methotrexate, nadolol, naltrexone hydrochloride and pentoxifylline in SyrSpend SF PH4 oral suspensions. EJHP 2016 ; 23: 352-358.
4177	文献	Polonini H, Loures da Silva S, Fernandes Brandao M.A, Bauters T, De Moerloose B, De Oliveira Ferreira A. Compatibility of Baclofen, Carvedilol, Hydrochlorothiazide, Mercaptopurine, Methadone Hydrochloride, Oseltamivir Phosphate, Phenobarbital, Propranolol Hydrochloride, Pyrazinamide, Sotalol Hydrochloride, Spironolactone, Tacrolimus Monohydrate, Ursodeoxycholic Acid, and Vancomycin Hydrochloride Oral Suspensions Compounded with SyrSpend SF PH4. Int J Pharm Compound 2018 ;22,6:516-526
4198	文献	Uriel M, Gomez-Rincon C, Marro D. Stability of regularly prescribed oral liquids formulated with SyrSpend® SF. Pharmazie 2018 73;196-201
4256	文献	Binson G, Beuzit K, Migeot V, Marco L, Troussier B, Venisse N, Dupuis A. Preparation and Physicochemical Stability of Liquid Oral Dosage Forms Free of Potentially Harmful Excipient Designed for Pediatric Patients. Pharmaceutics 2019 ;11,190:

Mentions Légales